Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 6:02 AM ET

Biotechnology

Company Overview of United Therapeutics Corporation

Company Overview

United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension (PAH). The company also provides Tyvaso, an inhaled prostacyclin therapy; and Adcirca, a once-daily oral therapy for the treatment of PAH. In addition, it develops Orenitram, a prostacyclin analog for treatment of PAH; Ch14.18 MAb, an antibody for the treatment of neuroblastoma; Beraprost 314d, which is under Phase III clinical trials for the treatment of PAH; and PLacental eXpanded cells t...

1040 Spring Street

Silver Spring, MD 20910

United States

Founded in 1996

740 Employees

Phone:

301-608-9292

Fax:

301-608-9291

Key Executives for United Therapeutics Corporation

Founder, Chairman and Co-Chief Executive Officer
Age: 60
Total Annual Compensation: $1.0M
Co-Chief Executive Officer, President and Director
Age: 53
Total Annual Compensation: $840.4K
Executive Vice President of Strategic Planning, General Counsel and Corporate Secretary
Age: 51
Total Annual Compensation: $731.0K
Compensation as of Fiscal Year 2014.

United Therapeutics Corporation Key Developments

United Therapeutics Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

United Therapeutics Corporation reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenue of $347,161,000 compared to $322,802,000 a year ago. Operating income was $171,705,000 compared to $176,320,000 a year ago. Income before income taxes was $168,334,000 compared to $173,033,000 a year ago. Net income was $99,211,000 compared to $111,852,000 a year ago. Diluted net income per share was $1.91 compared to $2.10 a year ago. Non-GAAP earnings were $132,517,000 compared to $118,655,000 a year ago. Diluted Non-GAAP earnings per share were $2.55 compared to $2.23 a year ago. For the six months, the company reported total revenue of $674,665,000 compared to $612,205,000 a year ago. Operating income was $156,879,000 compared to $392,460,000 a year ago. Income before income taxes was $151,542,000 compared to $386,249,000 a year ago. Net income was $82,570,000 compared to $249,376,000 a year ago. Diluted net income per share was $1.57 compared to $4.54 a year ago.

United Therapeutics Seeks Acquisitions

United Therapeutics Corporation (NasdaqGS:UTHR) announced that it has been engaged in active discussions with companies ranging from start-ups to top 10 drug companies looking to either acquire or in-license assets.

United Therapeutics Corporation to Report Q2, 2015 Results on Jul 28, 2015

United Therapeutics Corporation announced that they will report Q2, 2015 results at 9:00 AM, Eastern Standard Time on Jul 28, 2015

Similar Private Companies By Industry

Company Name Region
Axial Biotech, Inc. United States
Biomedica Inc. United States
Adrenergics, Inc. United States
TheraTarget, Inc. United States
Cresco Labs, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
August 19, 2015
United Therapeutics Corporation, Rare Pediatric Disease Priority Review Voucher Program
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact United Therapeutics Corporation, please visit www.unither.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.